Colorado BioScience Association Appoints New Board of Directors Leaders from OrganiShield and General Inception

For Immediate Release: March 19, 2024 Executives from Colorado State University, KBI Biopharma, Metro Denver Economic Development Corporation, Terumo Blood and Cell Technologies, and STAQ Pharma Join...

Learn More

Weekly Policy Blog: Campaign & Legislation Support Colorado’s Drive to Be a Leading Life Sciences Hub 

Colorado BioScience Association and a consortium of 22 Colorado partners have launched Colorado Hub for Health Impact, a new national economic development campaign to position Colorado as America’s ep...

Learn More

Weekly Policy Blog: CBSA’s 2024 Day at the Capitol 

CBSA held its annual Day at the Capitol event on February 28. CBSA members, legislators, and legislative staff first gathered for a health innovation company showcase and networking, which highlighted...

Learn More

Fitzsimons Innovation Community Partners with the Colorado Hub for Health Impact Campaign

Colorado’s health and life sciences industry gets a nationwide spotlight. If it has to do with health and innovation in Colorado, Fitzsimons Innovation Community is bound to be a part of it. We are es...

Learn More

New Consortium Launches Colorado Hub for Health Impact, a National Economic Development Campaign to Attract Health Innovation Companies to the State    

For Immediate Release: February 27, 2024 NEWS RELEASE 20+ Life Sciences Organizations, Economic Development Groups, Local Governments, Developers, and Builders Invest to Bring New, High-Growth Compani...

Learn More

Weekly Policy Blog: PDAB Initiates Upper Payment Limit Rulemaking Process for the First Time 

On Friday, February 23, the Colorado Prescription Drug Affordability Board (PDAB or Board) decided to initiate an “upper payment limit” (UPL) rulemaking process for the autoimmune disease drug Enbrel...

Learn More

Weekly Policy Blog: PDAB Deems One of Two Drugs “Unaffordable” in Recent Affordability Decisions 

On Friday, February 16, the Colorado Prescription Drug Affordability Board (PDAB or Board) completed its second and third affordability reviews, following its first decision on December 8 that the cys...

Learn More

Weekly Policy Blog: Legislative Session Update 

The first few weeks of the Colorado legislative session require intensive engagement at the Capitol and comprehensive review of proposed legislation by CBSA's Policy + Advocacy team to support a colla...

Learn More

Fitzsimons Innovation Community Presents Our Third Annual Innovation Report

A look at the accomplishments, progress, and innovation behind the buzz. At Fitzsimons Innovation Community, we know January is one of the best times to look forward, set goals, and make plans for the...

Learn More

Weekly Policy Blog: Take Action to Protect America’s Innovation Economy 

CBSA urges you to take action now to protect America’s innovation economy! The federal government is considering the use of “march-in rights” (where it could compel a patent-owner to license an invent...

Learn More